⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL28637308 | 0.84 | PRKCA (0.31) | — | |
| SCHEMBL16110280 | 0.82 | — | — | |
| SCHEMBL16109130 | 0.78 | — | — | |
| SCHEMBL636866 | 0.76 | GNAI3 (0.31) | — | |
| SCHEMBL22190739 | 0.75 | DPP4 (0.33) | — | |
| SCHEMBL28688162 | 0.72 | — | — | |
| SCHEMBL28031284 | 0.72 | GNAI3 (0.37) | — | |
| SCHEMBL21855942 | 0.72 | — | — | |
| SCHEMBL8763507 | 0.71 | — | — | |
| SCHEMBL30890403 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4090159-A1 | PYRAZOLYLPYRIMIDINES AND USE THEREOF | Biotheryx, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| EP-1773796-A2 | OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2007-04-18 | — | — | EP | claimed |
| WO-2006021655-A2 | OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2006-03-02 | — | — | WO | claimed |
| CN-118076581-A | Iron death modulators, their preparation and use | 维泰瑞隆有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-4090159-A1 | PYRAZOLYLPYRIMIDINES AND USE THEREOF | Biotheryx, Inc. (US) | 2022-11-23 | — | — | EP | disclosed |
| CN-108727363-B | Novel cyclin dependent kinase CDK9 inhibitor | 劲方医药科技(上海)有限公司 | 2020-06-19 | — | — | CN | disclosed |
| CN-108727363-A | A kind of novel cell cyclin-dependent kinase CDK9 inhibitor | 上海炯烁医药科技有限公司 | 2018-11-02 | — | — | CN | disclosed |